This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Adimab, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Monica Wai Ling Leung: Innovator in Antibody Development
Introduction
Monica Wai Ling Leung is a prominent inventor based in Summit, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific cellular mechanisms. Her work is crucial for advancing therapeutic strategies in immunology.
Latest Patents
Monica holds a patent for "Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use." This patent includes multispecific antibodies that exhibit desirable T-cell activation and targeted cell killing potency. The patent also outlines methods for identifying, isolating, and generating these antibodies, as well as reagents for their characterization.
Career Highlights
Monica is currently associated with Adimab, LLC, where she continues to innovate in the field of antibody engineering. Her expertise in developing anti-CD3 binding domains has positioned her as a key player in the biotechnology sector.
Collaborations
Monica has collaborated with notable colleagues, including Laura M Walker and Robert Pejchal, to further enhance the research and development of antibody technologies.
Conclusion
Monica Wai Ling Leung's contributions to antibody development are paving the way for new therapeutic approaches in immunology. Her innovative work continues to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile